The ban on importing Apple Watches to the United States has come to an end, posing challenges for both consumers and the tech giant itself. The ban was imposed by the U.S. International Trade Commission (ITC) in response to a complaint filed by health monitoring company Masimo, accusing Apple Watch of patent infringement related to its blood oxygen level monitoring feature. Despite the possibility of vetoing the ban within a 60-day period by the Biden administration, it was decided not to apply it. This decision applies to the import and sale of Apple watches with the discussed blood oxygen measurement function.
In response to the ban, Apple has decided to suspend the sales of its latest models – Series 9 and Ultra 2 – in the United States. However, the ban does not affect the cheaper Apple Watch SE model, which does not have the blood oxygen measurement feature and remains available for sale.
Although the ban specifically targets Apple and its affiliated entities, it may not have an impact on other retailers selling Apple watches. Models from the Series 9 Apple Watch could still be purchased on platforms like Amazon, Best Buy, and Walmart until December 26.
Masimo, the company that filed the complaint, has accused Apple of employee poaching and technology theft. The ongoing legal process between the two companies has seen Apple denying the patent infringement allegations.
To avoid the consequences of the ban, Apple plans to file an appeal with the Federal Circuit Court of Appeals in Washington. Additionally, the company reports that it is working on software changes to bypass the patent infringement claim. However, Masimo argues that its patents cover hardware, so a software solution may not be sufficient.
Despite the tense situation, Masimo’s CEO, Joe Kiani, has suggested the possibility of reaching a settlement. It remains to be seen how this case will unfold and how Apple will navigate the challenges resulting from the ban and potential legal and patent consequences.
In summary, the ban on importing Apple Watches to the United States represents a significant setback for Apple and creates uncertainty for consumers. The company must seek legal solutions, develop alternative options, or potentially reach a settlement to overcome this issue and regain access to the American market.